Construction of a fluorescein-responsive chimeric receptor with strict ligand dependency

Biotechnology and Bioengineering

Volumn 101, Issue 5, 2008, Pages 975-984

  Liu, Wenhai ^a   Kawahara, Masahiro ^a   Ueda, Hiroshi ^a   Nagamune, Teruyuki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Antibody; Erythropoietin receptor; gp130; Growth control; Juxtamembrane domain

Indexed keywords

ACTIVATION ANALYSIS; CELL PROLIFERATION; ENZYME ACTIVITY; ENZYME INHIBITION;

CELL FUNCTIONS; CELLULAR ENGINEERINGS; CHIMERIC RECEPTORS; CYTOKINE RECEPTORS; DO-MAINS; ERYTHROPOIETIN RECEPTOR; ERYTHROPOIETIN RECEPTORS; EXTRACELLULAR; EXTRACELLULAR DOMAINS; GP130; GROWTH CONTROL; INTRACELLULAR DOMAINS; JUXTAMEMBRANE DOMAIN; NATURAL LIGANDS; RECEPTOR CHIMERAS; RETROVIRAL VECTORS; SINGLE CHAINS; TRANSMEMBRANE DOMAINS;

LIGANDS;

CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; FLUORESCEIN; GLYCOPROTEIN GP 130; INTERLEUKIN 3; LIGAND; RETROVIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CHIMERA; MOUSE; NONHUMAN; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; ANTIGENS; CELL GROWTH PROCESSES; CELL LINE; CYTOKINE RECEPTOR GP130; DIMERIZATION; FLUORESCEIN; GENETIC VECTORS; IMMUNOGLOBULIN VARIABLE REGION; LIGANDS; MICE; PROTEIN ENGINEERING; RECEPTORS, ERYTHROPOIETIN; RECEPTORS, INTERLEUKIN-3; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 56449091024     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21961     Document Type: Article

References (39)

1. Burke F, Naylor MS, Davies B, Balkwill F. 1993. The cytokine wall chart. Immunol Today 14:165-170.
2. Chow D, He X, Snow AL, Rose-John S, Garcia KC. 2001. Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291:2150-2155.
3. Constantinescu SN, Liu X, Beyer W, Fallon A, Shekar S, Henis YI, Smith SO, Lodish HF. 1999. Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain. EMBO J 18:3334-3347.
4. Constantinescu SN, Huang LJ, Nam H, Lodish HF. 2001a. The erythropoietin receptor cytosolic juxtamembrane domain contains an essential, precisely oriented, hydrophobic motif. Mol Cell 7:377-385.
5. Constantinescu SN, Keren T, Socolovsky M, Nam H, Henis YI, Lodish HF. 2001b. Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 98:4379-4384.
6. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K, Hirano T. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5:449-460.
7. Ghattas IR, Sanes JR, Majors JE. 1991. The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos. Mol Cell Biochem 11:5848-5859.
8. Giese B, Roderburg C, Sommerauer M, Wortmann SB, Metz S, Heinrich PC, Muller-Newen G. 2005. Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J Cell Sci 118:5129-5140.
9. Greiser JS, Stross C, Heinrich PC, Behrmann I, Hermanns HM. 2002. Orientational constraints of the gp130 intracellular juxtamembrane domain for signaling. J Biol Chem 277:26959-26965.
10. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, Graeve L. 1998. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334:297-314.
11. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, Schaper F. 2003. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374:1-20.
12. Hirano T, Nakajima K, Hibi M. 1997. Signaling mechanisms through gp130: A model of the cytokine system. Cytokine Growth Factor Rev 8:241-252.
13. Huang LJ, Constantinescu SN, Lodish HF. 2001. The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Mol Cell 8:1327-1338.
14. Ihle JN. 2002. Cytokine receptor signalling. Nature 377:591-594.
15. Jin L, Zeng H, Chien S, Otto KG, Richard RE, Emery DW, Blau CA. 2000. In vivo selection using a cell-growth switch. Nat Genet 26:64-66.
16. Kawahara M, Ueda H, Tsumoto K, Kumagai I, Mahoney W, Nagamune T. 2002. Selection of highly productive mammalian cells based on an inducible growth advantage using an antibody/receptor chimera. J Biosci Bioeng 93:399-404.
17. Kawahara M, Kimura H, Ueda H, Nagamune T. 2004a. Selection of genetically modified cell population using hapten-specific antibody/receptor chimera. Biochem Biophys Res Commun 315:132-138.
18. Kawahara M, Ogo Y, Ueda H, Nagamune T. 2004b. Improved growth response of antibody/receptor chimera attained by the engineering of transmembrane domain. Protein Eng Des Sel 17:715-719.
19. Kawahara M, Ueda H, Tsumoto K, Kumagai I, Nagamune T. 2004c. AMEGA: Antigen-mediated genetically modified cell amplification. J Immunol Methods 284:187-194.
20. Kubatzky KF, Ruan W, Gurezka R, Cohen J, Ketteler R, Watowich SS, Neumann D, Langosch D, Klingmuller U. 2001. Self assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptor. Curr Biol 11:110-115.
21. Kubatzky KF, Liu W, Goldgraben K, Simmerling C, Smith SO, Constantinescu SN. 2005. Structural requirements of the extracellular to transmembrane domain junction for erythropoietin receptor function. J Biol Chem 280:14844-14854.
22. Kume A, Ito K, Ueda Y, Hasegawa M, Urabe M, Mano H, Ozawa K. 1999. A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells. Biochem Biophys Res Commun 260:9-12.
23. Kuwahara K, Saito Y, Kishimoto I, Miyamoto Y, Harada M, Ogawa E, Hamanaka I, Kajiyama N, Takahashi N, Izumi T, Kawakami R, Nakao K. 2000. Cardiotrophin-1 phosphorylates akt and BAD, and prolongs cell survival via a PI3K-dependent pathway in cardiac myocytes. J Mol Cell Cardiol 32:1385-1394.
24. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA. 1999. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987-990.
25. Lu X, Gross AW, Lodish HF. 2006. Active conformation of the erythropoietin receptor: Random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domains. J Biol Chem 281:7002-7011.
26. Morita S, Kojima T, Kitamura T. 2000. Plat-E: An efficient and stable system for transient packaging of retroviruses. Gene Ther 7:1063-1066.
27. Muller-Newen G, Kuster A, Wijdenes J, Schaper F, Heinrich PC. 2000. Studies on the interleukin-6-type cytokine signal transducer gp130 reveal a novel mechanism of receptor activation by monoclonal antibodies. J Biol Chem 275:4579-4586.
28. Neumann D, Yuk MH, Lodish HF, Lederkremer GZ. 1996. Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms. Biochem J 313:391-399.
29. Palacios R, Steinmetz M. 1985. Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41:727-734.
30. Persons DA, Allay JA, Allay ER, Smeyne RJ, Ashmun RA, Sorrentino BP, Nienhuis AW. 1997. Retroviral-mediated transfer of the green fluorescent protein gene into murine hematopoietic cells facilitates scoring and selection of transduced progenitors in vitro and identification of genetically modified cells in vivo. Blood 90:1777-1786.
31. Pihkala P, Kawahara M, Ueda H, Nagamune T. 2004. An antigen-mediated selection system for mammalian cells that produce glycosylated single-chain Fv. Biochem Biophys Res Commun 324:1165-1172.
32. Seubert N, Royer Y, Staerk J, Kubatzky KF, Moucadel V, Krishnakumar S, Smith SO, Constantinescu SN. 2003. Active and inactive orientations of the transmembrane and cytosolic domains of the erythropoietin receptor dimer. Mol Cell 12:1239-1250.
33. Skiniotis G, Boulanger MJ, Garcia KC, Walz T. 2005. Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor. Nat Struct Mol Biol 12:545-551.
34. Strobl B, Arulampalam V, Is'harc H, Newman SJ, Schlaak JF, Watling D, Costa-Pereira AP, Schaper F, Behrmann I, Sheehan KC, Schreiber RD, Horn F, Heinrich PC, Kerr IM. 2001. A completely foreign receptor can mediate an interferon-gamma-like response. EMBO J 20:5431-5442.
35. Sugimoto Y, Aksentijevich I, Murray GJ, Brady RO, Pastan I, Gottesman MM. 1995. Retroviral coexpression of a multidrug resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease. Hum Gene Ther 6:905-915.
36. Supino-Rosin L, Yoshimura A, Altaratz H, Neumann D. 1999. A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation. Eur J Biochem 263:410-419.
37. Tenhumberg S, Schuster B, Zhu L, Kovaleva M, Scheller J, Kallen KJ, Rose-John S. 2006. gp130 dimerization in the absence of ligand: Preformed cytokine receptor complexes. Biochem Biophys Res Commun 346:649-657.
38. Xu R, Kume A, Matsuda KM, Ueda Y, Kodaira H, Ogasawara Y, Urabe M, Kato I, Hasegawa M, Ozawa K. 1999. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells. J Gene Med 1:236-244.
39. Yoshimura A, D'Andrea AD, Lodish HF. 1990. Friend spleen focus-forming virus glycoprotein gp55 interacts with the erythropoietin receptor in the endoplasmic reticulum and affects receptor metabolism. Proc Natl Acad Sci USA 87:4139-4143.